Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01046643 · ClinicalTrials.gov registry record · NA
Early Menopause Hormone Treatment and Cognition
A NA study of Menopausal Syndrome, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT01046643 is a NA study of Menopausal Syndrome that has completed, run by University of Michigan. The registered enrollment target is 30 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01046643, a NA study of Menopausal Syndrome, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to evaluate the neurobiological effects of hormone therapy (HT) in healthy early postmenopausal women. The studies proposed in this project seek to define the association between different hormone forms (estradiol only and progesterone only) versus placebo on brain functional measures. The functional measures will include the performance of the volunteers on a comprehensive neuropsychological testing battery, and the brain functional responses to episodic memory (verbal and non-verbal) challenges as well as emotional processing determined with functional magnetic resonance imaging (fMRI).
Conditions Studied
Interventions
- DRUG Estradiol (E2)
- DRUG Progesterone (P10) x90
- DRUG Progesterone (P10) x10
Study Locations (1)
Michigan
- The University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2010-05 |
| Est. Completion | 2012-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01046643
The ClinicalTrials.gov registry entry for NCT01046643 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Menopausal Syndrome appearing as the primary indexed condition, and to 3 interventions - of which Estradiol (E2) is the first listed.
NCT01046643 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT01046643 about?
NCT01046643 is a clinical study titled "Early Menopause Hormone Treatment and Cognition". The objective of this study is to evaluate the neurobiological effects of hormone therapy (HT) in healthy early postmenopausal women. The studies proposed in this project seek to define the association between different hormone forms (estradiol only and progesterone only) versus placebo on brain fun...
What is the current status of trial NCT01046643?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2010-05. Estimated completion is 2012-03.
What conditions does trial NCT01046643 study?
This clinical trial studies the following conditions: Menopausal Syndrome.
What interventions are being tested in trial NCT01046643?
The interventions under investigation include: Estradiol (E2) (DRUG), Progesterone (P10) x90 (DRUG), Progesterone (P10) x10 (DRUG).
Who is sponsoring clinical trial NCT01046643?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01046643 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.